Hepatitis
- General information
- Widespread inflammation of the liver tissue with liver cell damage due to hepatic cell degeneration and necrosis; proliferation and enlargement of the Kupffer cells; inflammation of the periportal areas (may cause interruption of bile flow)
- Hepatitis A
- Incubation period: 15-45 days
- Transmitted by fecal/oral route: often occurs in crowded living conditions; with poor personal hygiene; or from contaminated food, milk, water, or shellfish
- Hepatitis B
- Incubation period: 50-180 days
- Transmitted by blood and body fluids (saliva, semen, vaginal secretions): often from contaminated needles among IV drug abusers; intimate/sexual contact
- Hepatitis C
- Incubation period: 7-50 days
- Transmitted by parenteral route: through blood and blood products, needles, syringes
- Assessment findings
- Preicteric stage
- Anorexia, nausea and vomiting, fatigue, constipation or diarrhea, weight loss
- Right upper quadrant discomfort, hepatomegaly, splenomegaly, lymphadenopathy
- Icteric stage
- Fatigue, weight loss, light-colored stools, dark urine
- Continued hepatomegaly with tenderness, lymphadenopathy, splenomegaly
- Jaundice, pruritus
- Posticteric stage
- Fatigue, but an increased sense of well-being
- Hepatomegaly gradually decreasing
- Diagnostic tests
- All three types of hepatitis
- SGPT (ALT), SGOT (AST), alkaline phosphatase, bilirubin, ESR: all increased (preicteric)
- leukocytes, lymphocytes, neutrophils: all decreased (pericteric)
- prolonged PT
- Hepatitis A
- hepatitis A virus (HAV) in stool before onset of disease
- anti-HAV (IgG) appears soon after onset of jaundice; peaks in 1-2 months and persists indefinitely
- anti-HAV (IgM): positive in acute infection; lasts 4-6 weeks
- Hepatitis B
- HBsAg (surface antigen): positive, develops 4-12 weeks after infection
- anti-HBsAG: negative in 80% of cases
- anti-HBc: associated with infectivity, develops 2-16 weeks after infection
- HBeAg: associated with infectivity and disappears before jaundice
- anti-HBe: present in carriers, represents low infectivity
- Hepatitis C: no specific serologic tests
- Nursing interventions
- Promote adequate nutrition.
- Administer antiemetics as ordered, 30 minutes before meals to decrease occurrence of nausea and vomiting.
- Provide small, frequent meals of a high-carbohydrate, moderate- to high-protein, high-vitamin, high-calorie diet.
- Avoid very hot or very cold foods.
- Ensure rest/relaxation: plan schedule for rest and activity periods, organize nursing care to minimize interruption.
- Monitor/relieve pruritus (see Cirrhosis of the Liver).
- Administer corticosteroids as ordered.
- Institute isolation procedures as required; pay special attention to good hand-washing technique and adequate sanitation.
- In hepatitis A administer immune serum globulin (ISG) early to exposed individuals as ordered.
- In hepatitis B
- Screen blood donors for HBsAg.
- Use disposable needles and syringes.
- Instruct client/others to avoid sexual intercourse while disease is active.
- Administer ISG to exposed individuals as ordered.
- Administer hepatitis B immunoglobulin (HBIG) as ordered to provide temporary and passive immunity to exposed individuals.
- To produce active immunity, administer hepatitis B vaccine to those individuals at high risk.
- In non-A, non-B: use disposable needles and syringes; ensure adequate sanitation.
- Provide client teaching and discharge planning concerning
- Importance of avoiding alcohol
- Avoidance of persons with known infections
- Balance of activity and rest periods
- Importance of not donating blood
- Dietary modifications
- Recognition and reporting of signs of inadequate convalescence: anorexia, jaundice, increasing liver tenderness/discomfort
- Techniques/importance of good personal hygiene
Tuesday, May 20, 2008
|
Labels:
liver disorder
|
This entry was posted on Tuesday, May 20, 2008
and is filed under
liver disorder
.
You can follow any responses to this entry through
the RSS 2.0 feed.
You can leave a response,
or trackback from your own site.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment